Valerie Brault

Title: Valerie Brault: Innovator in Melanocortin Receptor Research

Introduction

Valerie Brault is a prominent inventor based in Saint-Arnoult-en-Yvelines, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds targeting melanocortin receptors. With a total of 7 patents to her name, her work has the potential to impact the treatment of various pathological disorders.

Latest Patents

Among her latest patents, Valerie Brault has developed novel pyrimido-benzimidazole derivatives that serve as agonists or antagonists of melanocortin receptors. These compounds exhibit a strong affinity for specific melanocortin receptor sub-types, especially the MC4 receptors. This innovation holds promise for treating diseases associated with these receptors. Additionally, she has created benzimidazole and imidazopyridine derivatives, which also demonstrate good affinity for melanocortin receptors. These derivatives are particularly useful in addressing pathological states involving these receptors and are accompanied by pharmaceutical compositions for drug preparation.

Career Highlights

Valerie Brault has worked with notable companies in the pharmaceutical industry, including Ipsen Pharma S.a.s. and Société de Conseils de Recherches et d'Applications Scientifiques (S.C.R.A.S.). Her experience in these organizations has contributed to her expertise in drug development and innovation.

Collaborations

Throughout her career, Valerie has collaborated with esteemed colleagues such as Lydie Francine Poitout and Carole Sackur. These partnerships have further enriched her research and development efforts.

Conclusion

Valerie Brault's innovative work in the field of melanocortin receptor research showcases her dedication to advancing medicinal chemistry. Her patents and collaborations reflect her significant contributions to the scientific community.